Position in ONC
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$10,393
+$8,349 QoQ
Shares Held
35
+483.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BESSEMER GROUP INC holds $406,568,683 across 93 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
267,779 | $248,437,315 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
141,449 | $44,708,085 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
481,790 | $14,376,613 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
354,206 | $11,072,479 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
457,869 | $8,566,728 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
20,285 | $7,539,324 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
306,003 | $7,423,632 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
132,555 | $7,280,868 |
All Filings in ONC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,393 | 35 | Shares | Defined | 2026-05-06 | |
| 2025-09-30 | $2,044 | 6 | Shares | Defined | 2025-11-05 | |
| 2022-03-31 | $6,789 | 36 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,753 | 36 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $16,335 | 45 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,413 | 42 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $46,641 | 134 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,549,669 | 25,348 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $11,255,659 | 39,295 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||